Author

G. Montelatici

h-index 2 View on Semantic Scholar

We have 3 of 22 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Composite clinical scores in real-world extensive-stage small-cell lung cancer patients treated with chemo-immunotherapy.

BACKGROUND Composite scores such as Lung Immune Prognostic Index (LIPI), modified Glasgow Prognostic Score (mGPS), EPSILoN, Pan Immune-Inflammation Value (PIV) and Systemic Immune-Inflammation Index (SII) have shown prognostic value in solid tumors, but evidence in extensive-stage small-cell lung cancer (ES-SCLC) are l...

Teresa Beninato, Giulia Stasi, G. Montelatici et al. · Tumori · 0 citations

Review Open access Jul 2026

DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives

Delta-like ligand 3-directed therapies may reshape the management of DLL3-expressing prostate cancer if ongoing efforts to refine biomarkers improve patient enrichment and optimize trial design are successfully translated into clinical practice.

Giovanna Pecoraro, A. De Giorgi, G. Montelatici et al. · Drugs · 0 citations

Open access Jul 2026

Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models.

This is the first study to benchmark SLMs on Italian EHRs and investigate the role of clinical expertise in prompt engineering, offering valuable insights for the future integration of SLMs into real-world clinical workflows.

Federica Corso, V. Peppoloni, L. Mazzeo et al. · Communications Medicine · 0 citations